Indraprastha Medical [INDRAMEDCO] vs Unichem Laboratories [UNICHEMLAB] Detailed Stock Comparison
Indraprastha Medical
NSE
Loading...
Unichem Laboratories
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Indraprastha Medical wins in 10 metrics, Unichem Laboratories wins in 8 metrics, with 0 ties. Indraprastha Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Indraprastha Medical | Unichem Laboratories | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.75 | 28.25 | Indraprastha Medical |
| Price-to-Book Ratio | 7.52 | 1.44 | Unichem Laboratories |
| Debt-to-Equity Ratio | 5.49 | 18.76 | Indraprastha Medical |
| PEG Ratio | 1.79 | -0.13 | Unichem Laboratories |
| EV/EBITDA | 16.33 | 16.19 | Unichem Laboratories |
| Profit Margin (TTM) | 12.21% | 5.80% | Indraprastha Medical |
| Operating Margin (TTM) | 17.25% | -1.77% | Indraprastha Medical |
| EBITDA Margin (TTM) | 17.25% | N/A | N/A |
| Return on Equity | 26.98% | 5.61% | Indraprastha Medical |
| Return on Assets (TTM) | 18.90% | 3.85% | Indraprastha Medical |
| Free Cash Flow (TTM) | $1.20B | $-1.44B | Indraprastha Medical |
| Dividend Yield | 1.13% | N/A | N/A |
| 1-Year Return | -0.48% | -22.76% | Indraprastha Medical |
| Price-to-Sales Ratio (TTM) | 3.26 | 1.64 | Unichem Laboratories |
| Enterprise Value | $41.34B | $38.90B | Indraprastha Medical |
| EV/Revenue Ratio | 3.01 | 1.81 | Unichem Laboratories |
| Gross Profit Margin (TTM) | 38.19% | 53.47% | Unichem Laboratories |
| Revenue per Share (TTM) | $150 | $307 | Unichem Laboratories |
| Earnings per Share (Diluted) | $18.27 | $17.70 | Indraprastha Medical |
| Beta (Stock Volatility) | 0.61 | -0.17 | Unichem Laboratories |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Indraprastha Medical vs Unichem Laboratories Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Indraprastha Medical | -1.02% | 6.58% | 5.85% | 12.75% | 45.91% | -12.01% |
| Unichem Laboratories | -0.46% | 0.36% | 1.64% | -14.34% | -25.03% | -31.18% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Indraprastha Medical | -0.48% | 598.46% | 848.66% | 697.82% | 960.51% | 877.85% |
| Unichem Laboratories | -22.76% | 32.31% | 95.48% | 88.25% | 163.92% | 455.54% |
News Based Sentiment: Indraprastha Medical vs Unichem Laboratories
Indraprastha Medical
News based Sentiment: MIXED
Indraprastha Medical delivered improved profitability in Q1 FY2026, but slower revenue growth and an unclear price target from HDFC Securities create a mixed investment picture. The announcement of a strategic shift and new product line adds an element of potential, but requires further investigation.
Unichem Laboratories
News based Sentiment: MIXED
September brought both positive and negative developments for Unichem Laboratories. The USFDA EIR is a significant win, but the product recall and net loss create uncertainty. The long-term forecasts offer hope, but investors must navigate short-term volatility and address quality control concerns.
Performance & Financial Health Analysis: Indraprastha Medical vs Unichem Laboratories
| Metric | INDRAMEDCO | UNICHEMLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹44.25B | ₹35.23B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 159,391 | 31,505 |
| 90 Day Avg. Volume | 194,344 | 43,655 |
| Last Close | ₹471.85 | ₹503.75 |
| 52 Week Range | ₹307.25 - ₹572.00 | ₹483.00 - ₹937.95 |
| % from 52W High | -17.51% | -46.29% |
| All-Time High | ₹572.00 (Jan 06, 2025) | ₹937.95 (Nov 04, 2024) |
| % from All-Time High | -17.51% | -46.29% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.18% |
| Quarterly Earnings Growth | 0.15% | 0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.06% |
| Operating Margin (TTM) | 0.17% | -0.02% |
| Return on Equity (TTM) | 0.27% | 0.06% |
| Debt to Equity (MRQ) | 5.49 | 18.76 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹65.04 | ₹348.07 |
| Cash per Share (MRQ) | ₹35.08 | ₹12.72 |
| Operating Cash Flow (TTM) | ₹1.78B | ₹-1,166,300,000 |
| Levered Free Cash Flow (TTM) | ₹1.61B | ₹1.38B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.13% | N/A |
| Last 12-Month Dividend | ₹4.50 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Indraprastha Medical vs Unichem Laboratories
| Metric | INDRAMEDCO | UNICHEMLAB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.75 | 28.25 |
| Forward P/E | 195.50 | N/A |
| PEG Ratio | 1.79 | -0.13 |
| Price to Sales (TTM) | 3.26 | 1.64 |
| Price to Book (MRQ) | 7.52 | 1.44 |
| Market Capitalization | ||
| Market Capitalization | ₹44.25B | ₹35.23B |
| Enterprise Value | ₹41.34B | ₹38.90B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.01 | 1.81 |
| Enterprise to EBITDA | 16.33 | 16.19 |
| Risk & Other Metrics | ||
| Beta | 0.61 | -0.17 |
| Book Value per Share (MRQ) | ₹65.04 | ₹348.07 |
Financial Statements Comparison: Indraprastha Medical vs Unichem Laboratories
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | INDRAMEDCO | UNICHEMLAB |
|---|---|---|
| Revenue/Sales | ₹3.34B | ₹5.27B |
| Cost of Goods Sold | ₹2.13B | ₹2.45B |
| Gross Profit | ₹1.21B | ₹2.82B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹504.10M | ₹-93.00M |
| EBITDA | ₹676.70M | ₹293.10M |
| Pre-Tax Income | ₹552.70M | ₹-90.20M |
| Income Tax | ₹142.60M | ₹14.50M |
| Net Income (Profit) | ₹410.10M | ₹-104.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | INDRAMEDCO | UNICHEMLAB |
|---|---|---|
| Cash & Equivalents | ₹614.80M | ₹895.80M |
| Total Current Assets | ₹4.31B | ₹20.29B |
| Total Current Liabilities | ₹1.79B | ₹9.92B |
| Long-Term Debt | ₹305.40M | ₹860.00M |
| Total Shareholders Equity | ₹5.97B | ₹24.51B |
| Retained Earnings | N/A | ₹24.56B |
| Property, Plant & Equipment | ₹3.27B | ₹12.79B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | INDRAMEDCO | UNICHEMLAB |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | ₹-5.07B |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | INDRAMEDCO | UNICHEMLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 159,391 | 31,505 |
| Average Daily Volume (90 Day) | 194,344 | 43,655 |
| Shares Outstanding | 91.67M | 70.41M |
| Float Shares | 41.01M | 20.17M |
| % Held by Insiders | 0.58% | 0.71% |
| % Held by Institutions | 0.03% | 0.10% |
Dividend Analysis & Yield Comparison: Indraprastha Medical vs Unichem Laboratories
| Metric | INDRAMEDCO | UNICHEMLAB |
|---|---|---|
| Last 12-Month Dividend | ₹4.50 | ₹0.00 |
| Last 12-Month Dividend Yield | 1.13% | N/A |
| 3-Year Avg Annual Dividend | ₹3.33 | ₹1.33 |
| 3-Year Avg Dividend Yield | 2.17% | 1.34% |
| 3-Year Total Dividends | ₹10.00 | ₹4.00 |
| Ex-Dividend Date | Sep 13, 2024 | Aug 01, 2022 |